Table 5.
Code | Structure | Aβ40 Inhibition | Tau Inhibition a | ||
---|---|---|---|---|---|
% at 100 μM | IC50 (μM) | % at 10 μM | IC50 (μM) | ||
S22 b | -c | 15 ± 3 | |||
S23 b | 52 | 7.7 ± 1.0 | |||
S34 b | 20 | 16 ± 2 | |||
S35 b | 44 | 10 ± 2 | |||
4 | 31 ± 3 | 17 ± 2 | |||
5 | 22 ± 2 | 4.6 ± 0.7 | |||
6 | 45 ± 6 | 14 ± 2 | |||
7 | 2.0 ± 0.3 | 19 ± 2 | |||
8 | 69 ± 3 | 35 ± 2 | |||
9 | 0.95 ± 0.04 | 20 ± 2 |
a From cell-based assay. b Compounds and their data of β-amyloid aggregation are taken from ref. [16] and presented in Supplementary Materials. Values are mean ± SEM (n = 3) in in vitro assay. c No inhibition at 100 μM concentration.